Abuse of Amphetamines and Structural Abnormalities in the Brain

We review evidence that structural brain abnormalities are associated with abuse of amphetamines. A brief history of amphetamine use/abuse and evidence for toxicity is followed by a summary of findings from structural magnetic resonance imaging (MRI) studies of human subjects who had abused amphetamines and children who were exposed to amphetamines in utero. Evidence comes from studies that used a variety of techniques including manual tracing, pattern matching, voxel‐based, tensor‐based, or cortical thickness mapping, quantification of white matter signal hyperintensities, and diffusion tensor imaging. Ten studies compared controls to individuals who were exposed to methamphetamine. Three studies assessed individuals exposed to 3–4‐methylenedioxymethamphetamine (MDMA). Brain structural abnormalities were consistently reported in amphetamine abusers, as compared to control subjects. These included lower cortical gray matter volume and higher striatal volume than control subjects. These differences might reflect brain features that could predispose to substance dependence. High striatal volumes might also reflect compensation for toxicity in the dopamine‐rich basal ganglia. Prenatal exposure was associated with striatal volume that was below control values, suggesting that such compensation might not occur in utero. Several forms of white matter abnormality are also common and may involve gliosis. Many of the limitations and inconsistencies in the literature relate to techniques and cross‐sectional designs, which cannot infer causality. Potential confounding influences include effects of pre existing risk/protective factors, development, gender, severity of amphetamine abuse, abuse of other drugs, abstinence, and differences in lifestyle. Longitudinal designs in which multimodal datasets are acquired and are subjected to multivariate analyses would enhance our ability to provide general conclusions regarding the associations between amphetamine abuse and brain structure.

[1]  Nick C. Fox,et al.  Ten simple rules for reporting voxel-based morphometry studies , 2008, NeuroImage.

[2]  Stephen Taylor,et al.  Volume increases in striatum associated with positive symptom reduction in schizophrenia: A preliminary observation , 2005, Psychiatry Research: Neuroimaging.

[3]  Alan C. Evans,et al.  Developmental trajectories of brain volume abnormalities in children and adolescents with attention-deficit/hyperactivity disorder. , 2002, JAMA.

[4]  J. Monterosso,et al.  Changes in cerebral glucose metabolism during early abstinence from chronic methamphetamine abuse , 2008, Molecular Psychiatry.

[5]  B. Yamamoto,et al.  Interactions between methamphetamine and environmental stress: role of oxidative stress, glutamate and mitochondrial dysfunction. , 2007, Addiction.

[6]  D. Wong,et al.  Sensitivity to subjective effects of cocaine in drug abusers: relationship to cerebral ventricle size. , 1993, The American journal of psychiatry.

[7]  Martha Elizabeth Shenton,et al.  Voxel-Based Morphometric Analysis of Gray Matter in First Episode Schizophrenia , 2002, NeuroImage.

[8]  S. F. Witelson Hand and sex differences in the isthmus and genu of the human corpus callosum. A postmortem morphological study. , 1989, Brain : a journal of neurology.

[9]  Karl J. Friston,et al.  Why Voxel-Based Morphometry Should Be Used , 2001, NeuroImage.

[10]  G. C. Wagner,et al.  Methamphetamine-induced neuronal damage: A possible role for free radicals , 1989, Neuropharmacology.

[11]  M. Leider Goodman & Gilman's The Pharmacological Basis of Therapeutics , 1985 .

[12]  Liesbeth Reneman,et al.  A Prospective Cohort Study on Sustained Effects of Low-Dose Ecstasy Use on the Brain in New Ecstasy Users , 2007, Neuropsychopharmacology.

[13]  H. Cann,et al.  Use of d-amphetamine and related central nervous system stimulants in children. , 1973, Pediatrics.

[14]  J. Polich,et al.  Neuropsychology and neuropharmacology of P3a and P3b. , 2006, International journal of psychophysiology : official journal of the International Organization of Psychophysiology.

[15]  Robert Miller,et al.  Tardive Dyskinesia in the Era of Typical and Atypical Antipsychotics. Part 1: Pathophysiology and Mechanisms of Induction , 2005, Canadian journal of psychiatry. Revue canadienne de psychiatrie.

[16]  Jim Mintz,et al.  Brain ferritin iron may influence age- and gender-related risks of neurodegeneration , 2007, Neurobiology of Aging.

[17]  Shu-Wei Sun,et al.  Diffusion tensor imaging detects and differentiates axon and myelin degeneration in mouse optic nerve after retinal ischemia , 2003, NeuroImage.

[18]  L S Seiden,et al.  Methamphetamine and methylenedioxymethamphetamine neurotoxicity: possible mechanisms of cell destruction. , 1996, NIDA research monograph.

[19]  K. Frey,et al.  The vesicular monoamine transporter is not regulated by dopaminergic drug treatments. , 1995, European journal of pharmacology.

[20]  Karl J. Friston,et al.  Distributional Assumptions in Voxel-Based Morphometry , 2002, NeuroImage.

[21]  N. Volkow,et al.  Partial recovery of brain metabolism in methamphetamine abusers after protracted abstinence. , 2004, The American journal of psychiatry.

[22]  L. Johnston,et al.  Monitoring the Future national survey results on drug use, 1975-2017: Volume I, secondary school students , 2005 .

[23]  J. Cadet,et al.  Neuroadaptations in the dopaminergic system after active self-administration but not after passive administration of methamphetamine. , 1999, European journal of pharmacology.

[24]  U. C. Wieshmann,et al.  Comparison of standard and optimized voxel-based morphometry for analysis of brain changes associated with temporal lobe epilepsy , 2004, NeuroImage.

[25]  G. Gratton,et al.  Combining structural and functional neuroimaging data for studying brain connectivity: a review. , 2008, Psychophysiology.

[26]  Michael J. Schmidt,et al.  3H-amphetamine concentrations in the brains of young and aged rats: Implications for assessment of drug effects in aged animals , 1980, Neurobiology of Aging.

[27]  G. Bartzokis,et al.  Brain Volume: Age-Related Changes , 2009 .

[28]  H. W. Clark,et al.  Premorbid brain size is a determinant of functional reserve in abstinent crack-cocaine and crack-cocaine–alcohol-dependent adults , 1998, Journal of the International Neuropsychological Society.

[29]  Christos Davatzikos,et al.  Why voxel-based morphometric analysis should be used with great caution when characterizing group differences , 2004, NeuroImage.

[30]  Christine Fennema-Notestine,et al.  Effects of methamphetamine dependence and HIV infection on cerebral morphology. , 2005, The American journal of psychiatry.

[31]  D. Segal,et al.  Escalating dose-binge treatment with methylphenidate: role of serotonin in the emergent behavioral profile. , 1999, The Journal of pharmacology and experimental therapeutics.

[32]  J. Swanson,et al.  Pharmacokinetics of SLI381 (ADDERALL XR), an extended-release formulation of Adderall. , 2003, Journal of the American Academy of Child and Adolescent Psychiatry.

[33]  D. Segal,et al.  Repeated binge exposures to amphetamine and methamphetamine: behavioral and neurochemical characterization. , 1997, The Journal of pharmacology and experimental therapeutics.

[34]  P. Renshaw,et al.  Relationship between N-acetyl-aspartate in gray and white matter of abstinent methamphetamine abusers and their history of drug abuse: a proton magnetic resonance spectroscopy study. , 2007, Drug and Alcohol Dependence.

[35]  C. Advokat Literature Review: Update on Amphetamine Neurotoxicity and Its Relevance to the Treatment of ADHD , 2007, Journal of attention disorders.

[36]  Patrick M. O'Malley,et al.  Monitoring the Future: National Survey Results on Drug Use, 1975-2006. Volume II: College Students & Adults Ages 19-25. NIH Publication No. 07-6206. , 2007 .

[37]  George Bartzokis,et al.  Age-related brain volume reductions in amphetamine and cocaine addicts and normal controls: implications for addiction research , 2000, Psychiatry Research: Neuroimaging.

[38]  R F Spetzler,et al.  Incidental subcortical lesions identified on magnetic resonance imaging in the elderly. I. Correlation with age and cerebrovascular risk factors. , 1986, Stroke.

[39]  R. Gainetdinov,et al.  Increased Methamphetamine Neurotoxicity in Heterozygous Vesicular Monoamine Transporter 2 Knock-Out Mice , 1999, The Journal of Neuroscience.

[40]  R. Danielsson,et al.  Brain lipid composition in postnatal iron‐induced motor behavior alterations following chronic neuroleptic administration in mice , 2006, The FEBS journal.

[41]  A. Levey,et al.  Striatal dopamine nerve terminal markers in human, chronic methamphetamine users , 1996, Nature Medicine.

[42]  P. Renshaw,et al.  Decreased cerebral blood flow of the right anterior cingulate cortex in long-term and short-term abstinent methamphetamine users. , 2006, Drug and alcohol dependence.

[43]  Jim Mintz,et al.  Brain maturation may be arrested in chronic cocaine addicts , 2002, Biological Psychiatry.

[44]  Karl J. Friston,et al.  Automatic Differentiation of Anatomical Patterns in the Human Brain: Validation with Studies of Degenerative Dementias , 2002, NeuroImage.

[45]  T. Robinson,et al.  Reduced striatal vesicular monoamine transporters after neurotoxic but not after behaviorally-sensitizing doses of methamphetamine. , 1997, European journal of pharmacology.

[46]  F. Wan,et al.  Nomifensine attenuates d-amphetamine-induced dopamine terminal neurotoxicity in the striatum of rats. , 2000, The Chinese journal of physiology.

[47]  N. Volkow,et al.  Structural and metabolic brain changes in the striatum associated with methamphetamine abuse. , 2007, Addiction.

[48]  R F Spetzler,et al.  Incidental subcortical lesions identified on magnetic resonance imaging in the elderly. II. Postmortem pathological correlations. , 1986, Stroke.

[49]  N. A. Thacker,et al.  Tutorial: A Critical Analysis of Voxel Based Morphometry (VBM). , 2003 .

[50]  Graeme D. Jackson,et al.  Composite voxel-based analysis of volume and T2 relaxometry in temporal lobe epilepsy , 2008, NeuroImage.

[51]  J. O'Callaghan,et al.  Age as a Susceptibility Factor in the Striatal Dopaminergic Neurotoxicity Observed in the Mouse following Substituted Amphetamine Exposure , 2000, Annals of the New York Academy of Sciences.

[52]  T. Robbins,et al.  Dissociable Deficits in the Decision-Making Cognition of Chronic Amphetamine Abusers, Opiate Abusers, Patients with Focal Damage to Prefrontal Cortex, and Tryptophan-Depleted Normal Volunteers: Evidence for Monoaminergic Mechanisms , 1999, Neuropsychopharmacology.

[53]  C. Kassed,et al.  Brain injury: prolonged induction of transcription factors. , 2000, Acta neurobiologiae experimentalis.

[54]  K. Johnson-Davis,et al.  Age-Dependent Methamphetamine-Induced Alterations in Vesicular Monoamine Transporter-2 Function: Implications for Neurotoxicity , 2005, Journal of Pharmacology and Experimental Therapeutics.

[55]  Linda Chang,et al.  Enlarged striatum in abstinent methamphetamine abusers: A possible compensatory response , 2005, Biological Psychiatry.

[56]  G. Bartzokis,et al.  The incidence of T2-weighted MR imaging signal abnormalities in the brain of cocaine-dependent patients is age-related and region-specific. , 1999, AJNR. American journal of neuroradiology.

[57]  E. Check Psychedelic drugs: The ups and downs of ecstasy , 2004, Nature.

[58]  K. Frey,et al.  Effects of dopaminergic drug treatments on in vivo radioligand binding to brain vesicular monoamine transporters. , 1996, Nuclear medicine and biology.

[59]  Nora D. Volkow,et al.  Modifications radiologiques et neurologiques chez les toxicomanes: étude par résonance magnétique , 1988 .

[60]  W. Melega,et al.  Recovery from methamphetamine induced long-term nigrostriatal dopaminergic deficits without substantia nigra cell loss , 2000, Brain Research.

[61]  R. Doblin A Clinical Plan for MDMA (Ecstasy) in the Treatment of Posttraumatic Stress Disorder (PTSD): Partnering with the FDA , 2002, Journal of psychoactive drugs.

[62]  Michael A Downes,et al.  Amphetamine‐induced movement disorder , 2005, Emergency medicine Australasia : EMA.

[63]  U. McCann,et al.  Amphetamine Treatment Similar to That Used in the Treatment of Adult Attention-Deficit/Hyperactivity Disorder Damages Dopaminergic Nerve Endings in the Striatum of Adult Nonhuman Primates , 2005, Journal of Pharmacology and Experimental Therapeutics.

[64]  P. Renshaw,et al.  Reduced cortical gray matter density in human MDMA (Ecstasy) users: a voxel-based morphometry study. , 2003, Drug and alcohol dependence.

[65]  N. Volkow,et al.  Loss of Dopamine Transporters in Methamphetamine Abusers Recovers with Protracted Abstinence , 2001, The Journal of Neuroscience.

[66]  In Chan Song,et al.  Shape changes of the corpus callosum in abstinent methamphetamine users , 2005, Neuroscience Letters.

[67]  E. Bender FDA Approves Study of Ecstasy In Some Terminally Ill Patients , 2005 .

[68]  In Chan Song,et al.  Decreased frontal white-matter integrity in abstinent methamphetamine abusers. , 2007, The international journal of neuropsychopharmacology.

[69]  P. Riederer,et al.  The dopamine receptor agonist lisuride attenuates iron-mediated dopaminergic neurodegeneration , 2003, Experimental Neurology.

[70]  Linda Chang,et al.  Perfusion MRI and computerized cognitive test abnormalities in abstinent methamphetamine users , 2002, Psychiatry Research: Neuroimaging.

[71]  Fred L. Bookstein,et al.  “Voxel-Based Morphometry” Should Not Be Used with Imperfectly Registered Images , 2001, NeuroImage.

[72]  Bennett A. Landman,et al.  Statistical parametric mapping of brain morphology: Sensitivity is dramatically increased by using brain-extracted images as inputs , 2006, NeuroImage.

[73]  Dennis C Harvey,et al.  Methamphetamine increases basal ganglia iron to levels observed in aging , 2007, Neuroreport.

[74]  NTP-CERHR monograph on the potential human reproductive and developmental effects of amphetamines. , 2005, NTP CERHR MON.

[75]  G. C. Wagner,et al.  Current research on methamphetamine-induced neurotoxicity: animal models of monoamine disruption. , 2003, Journal of pharmacological sciences.

[76]  J. Dunnick,et al.  Decreases in spontaneous tumors in rats and mice after treatment with amphetamine. , 1991, Toxicology.

[77]  Richard S. J. Frackowiak,et al.  Navigation-related structural change in the hippocampi of taxi drivers. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[78]  Seiden Ls,et al.  Methamphetamine and methylenedioxymethamphetamine neurotoxicity: possible mechanisms of cell destruction. , 1996 .

[79]  C. Harper,et al.  Ethanol and brain damage. , 2005, Current opinion in pharmacology.

[80]  Walter Ling,et al.  Mood disturbances and regional cerebral metabolic abnormalities in recently abstinent methamphetamine abusers. , 2004, Archives of general psychiatry.

[81]  G. Bartzokis BRAIN MYELINATION IN PREVALENT NEUROPSYCHIATRIC DEVELOPMENTAL DISORDERS: PRIMARY AND COMORBID ADDICTION. , 2005, Adolescent psychiatry.

[82]  David Araújo,et al.  Correlation between voxel based morphometry and manual volumetry in magnetic resonance images of the human brain. , 2008, Anais da Academia Brasileira de Ciencias.

[83]  G. Teuchert-Noodt,et al.  Age-related toxicity in prefrontal cortex and caudate-putamen complex of gerbils (Meriones unguiculatus) after a single dose of methamphetamine , 1991, Neuropharmacology.

[84]  M. Bannon,et al.  Gene expression profile of the nucleus accumbens of human cocaine abusers: evidence for dysregulation of myelin , 2004, Journal of neurochemistry.

[85]  Patrick M. O'Malley,et al.  Monitoring the Future National Results on Adolescent Drug Use: Overview of Key Findings, 2004. , 2003 .

[86]  T. Beveridge,et al.  Psychostimulants and monoamine transporters: upsetting the balance. , 2005, Current opinion in pharmacology.

[87]  Karl J. Friston,et al.  Voxel-Based Morphometry—The Methods , 2000, NeuroImage.

[88]  A. Morton,et al.  Methamphetamine toxicity in mice is potentiated by exposure to loud music , 2001, Neuroreport.

[89]  S. Lawrie,et al.  Voxel-based morphometry of grey matter densities in subjects at high risk of schizophrenia , 2003, Schizophrenia Research.

[90]  Andreas Meyer-Lindenberg,et al.  False positives in imaging genetics , 2008, NeuroImage.

[91]  Christian Beaulieu,et al.  Voxel based versus region of interest analysis in diffusion tensor imaging of neurodevelopment , 2007, NeuroImage.

[92]  P. Renshaw,et al.  Prefrontal grey-matter changes in short-term and long-term abstinent methamphetamine abusers. , 2005, The international journal of neuropsychopharmacology.

[93]  Michael H. Baumann,et al.  3,4-Methylenedioxymethamphetamine (MDMA) neurotoxicity in rats: a reappraisal of past and present findings , 2006, Psychopharmacology.

[94]  P. Renshaw,et al.  White matter hyperintensities in subjects with cocaine and opiate dependence and healthy comparison subjects , 2004, Psychiatry Research: Neuroimaging.

[95]  Sushil K. Sharma,et al.  Attenuation of Cocaine and Methamphetamine Neurotoxicity by Coenzyme Q10 , 2006, Neurochemical Research.

[96]  G. Pearlson,et al.  Decreased frontal white-matter volume in chronic substance abuse. , 2005, The international journal of neuropsychopharmacology.

[97]  P. Thompson,et al.  Relationship among neuroimaging indices of cerebral health during normal aging , 2008, Human brain mapping.

[98]  C. Chi,et al.  Baicalein attenuates methamphetamine-induced loss of dopamine transporter in mouse striatum. , 2006, Toxicology.

[99]  S. Kish,et al.  Why is parkinsonism not a feature of human methamphetamine users? , 2004, Brain : a journal of neurology.

[100]  J. Krystal,et al.  Psychopharmacology: The Third Generation of Progress , 1989, The Yale Journal of Biology and Medicine.

[101]  Paul M. Thompson,et al.  Structural Abnormalities in the Brains of Human Subjects Who Use Methamphetamine , 2004, The Journal of Neuroscience.

[102]  Jonathan D. Cohen,et al.  Decision making, the P3, and the locus coeruleus-norepinephrine system. , 2005, Psychological bulletin.

[103]  Neil Roberts,et al.  Voxel-Based Morphometric Comparison of Hippocampal and Extrahippocampal Abnormalities in Patients with Left and Right Hippocampal Atrophy , 2002, NeuroImage.

[104]  H. Sumnall,et al.  Altered states: the clinical effects of Ecstasy. , 2003, Pharmacology & therapeutics.

[105]  Rodney J. Croft,et al.  The relative contributions of ecstasy and cannabis to cognitive impairment , 2001, Psychopharmacology.

[106]  P. Sonsalla,et al.  Analysis of VMAT2 Binding After Methamphetamine or MPTP Treatment , 2000, Journal of neurochemistry.

[107]  A. Levey,et al.  Dopamine transporters and neuronal injury. , 1999, Trends in pharmacological sciences.

[108]  C. Achat-Mendes,et al.  Impairment in Consolidation of Learned Place Preference Following Dopaminergic Neurotoxicity in Mice is Ameliorated by N-acetylcysteine but not D1 and D2 Dopamine Receptor Agonists , 2007, Neuropsychopharmacology.

[109]  G. Bartzokis,et al.  Tardive dyskinesia and serum iron indices , 1998, Biological Psychiatry.

[110]  J. Rapoport,et al.  Differential effects of methylphenidate and dextroamphetamine on the motor activity level of hyperactive children. , 1989, Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology.

[111]  P. Renshaw,et al.  Increased white matter hyperintensities in male methamphetamine abusers. , 2006, Drug and alcohol dependence.

[112]  N. Volkow,et al.  Radiological and neurological changes in the drug abuse patient: a study with MRI. , 1988, Journal of neuroradiology. Journal de neuroradiologie.

[113]  D. Pubill,et al.  Methyllycaconitine Prevents Methamphetamine-Induced Effects in Mouse Striatum: Involvement of α7 Nicotinic Receptors , 2005, Journal of Pharmacology and Experimental Therapeutics.

[114]  Khader M Hasan,et al.  Diffusion Tensor Imaging in MDMA Users and Controls: Association with Decision Making , 2007, The American journal of drug and alcohol abuse.

[115]  B. Madras,et al.  The Dopamine Transporter and Attention-Deficit/Hyperactivity Disorder , 2005, Biological Psychiatry.

[116]  Robert Turner,et al.  Voxel-based cortical thickness measurements in MRI , 2008, NeuroImage.

[117]  E. Jodo,et al.  Effects of repeated administration of methamphetamine on P3-like potentials in rats. , 1999, International journal of psychophysiology : official journal of the International Organization of Psychophysiology.

[118]  W. Slikker,et al.  Effects of a cold environment or age on methamphetamine-induced dopamine release in the caudate putamen of female rats , 1993, Pharmacology Biochemistry and Behavior.

[119]  U. McCann,et al.  Methylphenidate and brain dopamine neurotoxicity , 1997, Brain Research.

[120]  P. Phansuwan-Pujito,et al.  Melatonin protects SK‐N‐SH neuroblastoma cells from amphetamine‐induced neurotoxicity , 2007, Journal of pineal research.

[121]  G. Bartzokis,et al.  Age-related changes in frontal and temporal lobe volumes in men: a magnetic resonance imaging study. , 2001, Archives of general psychiatry.

[122]  Karl J. Friston,et al.  A Voxel-Based Morphometric Study of Ageing in 465 Normal Adult Human Brains , 2001, NeuroImage.

[123]  F. Benes,et al.  Myelination of a key relay zone in the hippocampal formation occurs in the human brain during childhood, adolescence, and adulthood. , 1994, Archives of general psychiatry.

[124]  S. Haber,et al.  Striatal Responses to Partial Dopaminergic Lesion: Evidence for Compensatory Sprouting , 2000, The Journal of Neuroscience.

[125]  R. Rawson,et al.  Why do we need an Addiction supplement focused on methamphetamine? , 2007, Addiction.

[126]  Eve C. Johnstone,et al.  Structural Gray Matter Differences between First-Episode Schizophrenics and Normal Controls Using Voxel-Based Morphometry , 2002, NeuroImage.

[127]  Linda Chang,et al.  Smaller subcortical volumes and cognitive deficits in children with prenatal methamphetamine exposure , 2004, Psychiatry Research: Neuroimaging.

[128]  J S Fowler,et al.  Higher cortical and lower subcortical metabolism in detoxified methamphetamine abusers. , 2001, The American journal of psychiatry.

[129]  E. Gouzoulis-Mayfrank,et al.  Neurotoxicity of methylenedioxyamphetamines (MDMA; ecstasy) in humans: how strong is the evidence for persistent brain damage? , 2006, Addiction.

[130]  Ganesan Venkatasubramanian,et al.  IMAGING STUDY: Gray matter volume abnormalities and externalizing symptoms in subjects at high risk for alcohol dependence , 2007, Addiction biology.

[131]  C. Abraham,et al.  Social cognitive determinants of ecstasy use to target in evidence-based interventions: a meta-analytical review , 2008, Addiction.

[132]  C. Hanstock,et al.  Lithium and valproate protect against dextro-amphetamine induced brain choline concentration changes in bipolar disorder patients , 2004, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.